Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis. (Q43299273)
Jump to navigation
Jump to search
scientific article published on 3 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis. |
scientific article published on 3 August 2009 |
Statements
Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis (English)
Kathleen M Gillooly
Mark A Pattoli
Tracy L Taylor
Laishun Chen
Lihong Cheng
Kurt R Gregor
Gena S Whitney
Vojkan Susulic
James Kempson
William J Pitts
Hollie Booth-Lute
Guchen Yang
Paul Davies
Daniel W Kukral
Joann Strnad
Kim W McIntyre
Celia J Darienzo
Luisa Salter-Cid
Zheng Yang
David B Wang-Iverson